Montelukast sodium
- ₹5700 - ₹53334.78
- Product name: Montelukast sodium
- CAS: 151767-02-1
- MF: C35H37ClNNaO3S
- MW: 610.18
- EINECS:604-813-7
- MDL Number:MFCD00931431
- Synonyms:montelucast-d6;Montelukast Soudium Tablets;Montelukast sodium ,99%;1-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-Methylethyl)phenyl]propyl]thio]Methyl]cyclopropaneacetic Acid SodiuM Salt;Montelukast SoudiuM;MONTELUKST SODIUM;MONTELUKAST SODIUM;MK-476, Singulair
5 prices
Selected condition:
Brand
- Sigma-Aldrich(India)
- TCI Chemicals (India)
Package
- 10MG
- 50MG
- 200MG
- 1G
- ManufacturerSigma-Aldrich(India)
- Product numberSML0101
- Product descriptionMontelukast sodium hydrate ≥98% (HPLC)
- Packaging50MG
- Price₹53334.78
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberSML0101
- Product descriptionMontelukast sodium hydrate ≥98% (HPLC)
- Packaging10MG
- Price₹13228.15
- Updated2022-06-14
- Buy
- ManufacturerTCI Chemicals (India)
- Product numberM2340
- Product descriptionMontelukast Sodium
- Packaging1G
- Price₹8100
- Updated2022-05-26
- Buy
- ManufacturerTCI Chemicals (India)
- Product numberM2340
- Product descriptionMontelukast Sodium
- Packaging200MG
- Price₹5700
- Updated2022-05-26
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberPHR1603
- Product descriptionMontelukast Sodium Pharmaceutical Secondary Standard; Certified Reference Material
- Packaging1G
- Price₹12416.28
- Updated2022-06-14
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich(India) | SML0101 | Montelukast sodium hydrate ≥98% (HPLC) | 50MG | ₹53334.78 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | SML0101 | Montelukast sodium hydrate ≥98% (HPLC) | 10MG | ₹13228.15 | 2022-06-14 | Buy |
TCI Chemicals (India) | M2340 | Montelukast Sodium | 1G | ₹8100 | 2022-05-26 | Buy |
TCI Chemicals (India) | M2340 | Montelukast Sodium | 200MG | ₹5700 | 2022-05-26 | Buy |
Sigma-Aldrich(India) | PHR1603 | Montelukast Sodium Pharmaceutical Secondary Standard; Certified Reference Material | 1G | ₹12416.28 | 2022-06-14 | Buy |
Properties
Melting point :115 °C(dec.)
storage temp. :2-8°C
solubility :DMSO: ≥8mg/mL at 60°C
form :powder
color :white to tan
optical activity :[α]/D +90 to +106° in methanol (c=1)
Merck :14,6258
BCS Class :1
Stability :Stable for 1 year from date of purchase as supplied. Solutions in DMSO, distilled water, or ethanol may be stored at -20°C for up to 1 month.
InChIKey :LBFBRXGCXUHRJY-HKHDRNBDSA-M
storage temp. :2-8°C
solubility :DMSO: ≥8mg/mL at 60°C
form :powder
color :white to tan
optical activity :[α]/D +90 to +106° in methanol (c=1)
Merck :14,6258
BCS Class :1
Stability :Stable for 1 year from date of purchase as supplied. Solutions in DMSO, distilled water, or ethanol may be stored at -20°C for up to 1 month.
InChIKey :LBFBRXGCXUHRJY-HKHDRNBDSA-M
Safety Information
Symbol(GHS): | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||
Hazard statements: |
|
||||||||||||||
Precautionary statements: |
|
Description
Montelukast was launched as Singulair in Mexico and Finland for the management of mild to moderate asthma inadequately controlled by inhaled corticosteroids and short-acting beta2-agonists. Montelukast can be obtained by an seven-step synthesis from 3-[2(E)-(7-chloroquinolin-2-yl)vinyl] benzaldehyde. Montelukast is a potent, selective and orally active antagonist of the CysLT1 (formerly called LTD4) receptor, thus blocking the effects of the cysteinyl leukotrienes LTC4, LTD4 and LTE4 on microvascular permeability and the activation of eosinophils. Montelukast represents the third molecule of this class which has been approved in asthma after pranlukast (1995) and zafirlukast (1996). Montelukast has been studied extensively in placebo-controlled clinical trials, in mildly or severe asthmatic patients challenged with LTD4 or exercise. A variety of acute bronchoconstricting challenges were inhibited or attenuated with all doses used. Montelukast demonstrated clinically significant improvements in the parameters of asthma control associated with an appreciable improvement in quality of life., reducing days with asthma exacerbations and allowing significant tapering of corticosteroids. Montelukast is well-tolerated and only needs to be administered once a day.More related product prices
Sodium acetate Sodium chloride Sodium hydroxide CHLOROPHOSPHONAZO III Sodium chlorite Tribenuron methyl Sodium bicarbonate Kresoxim-methyl Sodium benzoate Diclofenac sodium Sodium sulfate Methyl salicylate 74223-64-6 Methyl [E]-2-[3-(S)-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]benzoate Methyl bromide Cyclopropylacetic acid 162515-68-6Related product price
- Sodium acetate
₹310-188090 - Sodium chloride
₹210-832778.08 - Sodium hydroxide
₹135-62709.23